Trade Summary

Yesterday, Diraimondo Thomas, serving as Chief Scientific Officer at Janux Therapeutics, Inc. (JANX), sold 2,505 shares at $13.73 per share, for a total transaction value of $34,394.00. Following this transaction, Diraimondo Thomas now holds 155,825 shares of JANX.

This sale represents a 2.00% decrease in Diraimondo Thomas's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, January 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, meaning the disclosure happened on the same day as the trade.

Janux Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.